PLEKHA8P1 Promotes Tumor Progression and Indicates Poor Prognosis of Liver Cancer

Hepatocellular carcinoma (HCC) records the second-lowest 5-year survival rate despite the avalanche of research into diagnosis and therapy. One of the major obstacles in treatment is chemoresistance to drugs such as 5-fluorouracil (5-FU), making identification and elucidation of chemoresistance regu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jiyeon, Hwang, Ji-Hyun, Chun, Harim, Woo, Wonjin, Oh, Sekyung, Choi, Jungmin, Kim, Lark Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304620/
https://www.ncbi.nlm.nih.gov/pubmed/34299245
http://dx.doi.org/10.3390/ijms22147614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304620/
https://www.ncbi.nlm.nih.gov/pubmed/34299245
http://dx.doi.org/10.3390/ijms22147614

Ejemplares similares